Skip to main content

Advertisement

Log in

Prevalence, incidence and persistence of anti-asthma medication use in 2- to 29-year-olds: a nationwide prescription study

  • Pharmacoepidemiology and Prescription
  • Published:
European Journal of Clinical Pharmacology Aims and scope Submit manuscript

Abstract

Purpose

The purpose of this study was to examine gender- and age-specific prevalence, incidence, and the type of anti-asthma medications used in the Norwegian population aged 2–29 years during 2005–2007 and to estimate the share of individuals who regularly redeemed medications over a 3-year period.

Methods

We retrieved data from the nationwide Norwegian Prescription Database for all individuals 2–29 years old (n = 1.7 million) who received anti-asthma medications during 2005–2007. Medications included inhaled short- and long-acting β2-agonists, inhaled corticosteroids, fixed-dose combinations of inhaled β2-agonists and corticosteroids, and leukotriene antagonists.

Results

In 2007, 5.5% (92,074 individuals) of Norwegians aged 2–29 years received anti-asthma medication, and this figure was stable throughout 2005–2007. Prevalence and incidence were higher among males than females but shifted to female dominance during adolescence. The share of anti-asthma medication users who received inhaled corticosteroids was high in preschool children but decreased by age. Conversely, use of inhaled β2-agonists as monotherapy and of fixed combinations increased with age. Fewer than half the individuals were “persistent” to medication treatment for 3 years by redeeming prescriptions regularly (at least once a year).

Conclusions

In this nationwide study, annual prevalence of anti-asthma medication use was stable during 2005–2007. The gender- and age-specific profile of prevalence and incidence correspond well with other studies. Fewer than half the individuals redeemed prescriptions regularly over 3 years.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  1. The International Study of Asthma and Allergies in Childhood (ISAAC) Steering Committee (1998) Worldwide variation in prevalence of symptoms of asthma, allergic rhinoconjunctivitis, and atopic eczema: ISAAC. Lancet 351:1225–1232

    Google Scholar 

  2. Anderson HR, Ruggles R, Strachan DP, Austin JB, Burr M, Jeffs D, Standring P, Steriu A, Goulding R (2004) Trends in prevalence of symptoms of asthma, hay fever, and eczema in 12–14 year olds in the British Isles, 1995–2002: questionnaire survey. Br Med J 328:1052–1053

    Article  Google Scholar 

  3. von Hertzen L, Haahtela T (2005) Signs of reversing trends in prevalence of asthma. Allergy 60:283–292

    Article  Google Scholar 

  4. Rees J (2005) ABC of asthma—Prevalence. Br Med J 331:443–445

    Article  Google Scholar 

  5. Burney P (2002) The changing prevalence of asthma? Thorax 57:36–39

    Google Scholar 

  6. National Heart Lung and Blood Institute (NHLBI) (2007) Expert Panel Report 3 (EPR3): guidelines for the diagnosis and management of asthma

  7. Global Initiative for Asthma (GINA) (2007) Global strategy for asthma management and prevention

  8. Furu K, Skurtveit S, Langhammer A, Nafstad P (2007) Use of anti-asthmatic medications as a proxy for prevalence of asthma in children and adolescents in Norway: a nationwide prescription database analysis. Eur J Clin Pharmacol 63:693–698

    Article  CAS  PubMed  Google Scholar 

  9. Furu K (2008) Establishment of the nationwide Norwegian Prescription Database (NorPD)—new opportunities for research in pharmacoepidemiology in Norway. Nor J Epidemiol 18:129–136

    Google Scholar 

  10. WHO Collaborating Centre for Drug Statistics Methodology. Norwegian Institute of Public Health (2008) Guidelines for ATC classification and DDD assignment. Norway, Oslo

    Google Scholar 

  11. Hågå A, Sverre JM (2002) Pricing and reimbursement of pharmaceuticals in Norway. Eur J Health Economics 3:215–220

    Article  Google Scholar 

  12. Hallas J (2005) Drug utilization statistics for individual-level pharmacy dispensing data. Pharmacoepidemiol Drug Saf 14:455–463

    Article  PubMed  Google Scholar 

  13. Caetano PA, Lam JM, Morgan SG (2006) Toward a standard definition and measurement of persistence with drug therapy: examples from research on statin and antihypertensive utilization. Clin Ther 28:1411–1424

    Article  PubMed  Google Scholar 

  14. Mäkelä MJ, Virta L, Kaila M, Grönlund J, Vanto T, Klaukka T (2008) Medication use in children with asthma in Finland from 1995 to 2006. J Allergy Clin Immunol 122:648–649

    Article  PubMed  Google Scholar 

  15. Drazen JM, O’Byrne PM (2009) Risks of long-acting beta-agonists in achieving asthma control. N Engl J Med 360:1671–1672

    Article  CAS  PubMed  Google Scholar 

  16. Nafstad P, Magnus P, Jaakkola JJK (2000) Early respiratory infections and childhood asthma. Pediatrics 106:e38

    Article  CAS  PubMed  Google Scholar 

  17. Nafstad P, Brunekreef B, Skrondal A, Nystad W (2005) Early respiratory infections, asthma, and allergy: 10-year follow-up of the Oslo Birth Cohort. Pediatrics 116:e255–e262

    Article  PubMed  Google Scholar 

  18. Selnes A, Nystad W, Bolle R, Lund E (2005) Diverging prevalence trends of atopic disorders in Norwegian children. Results from three cross-sectional studies. Allergy 60:894–899

    Article  CAS  PubMed  Google Scholar 

  19. Carlsen KCL, Haland G, Devulapalli CS, Munthe-Kaas M, Pettersen M, Granum B, Lovik M, Carlsen KH (2006) Asthma in every fifth child in Oslo, Norway: a 10-year follow up of a birth cohort study*. Allergy 61:454–460

    Article  PubMed  Google Scholar 

  20. Tollefsen E, Bjermer L, Langhammer A, Johnsen R, Holmen TL (2006) Adolescent respiratory symptoms-girls are at risk: the Young-HUNT study, Norway. Respir Med 100:471–476

    Article  PubMed  Google Scholar 

  21. de Vries TW, Tobi H, Schirm E, van den Berg P, Duiverman EJ, de Jong-Van den Berg LT (2006) The gap between evidence-based medicine and daily practice in the management of paediatric asthma. A pharmacy-based population study from The Netherlands. Eur J Clin Pharmacol 62:51–55

  22. Osman M (2003) Therapeutic implications of sex differences in asthma and atopy. Arch Dis Child 88:587–590

    Article  CAS  PubMed  Google Scholar 

  23. Wright AL, Stern DA, Kauffmann F, Martinez FD (2006) Factors influencing gender differences in the diagnosis and treatment of asthma in childhood: the Tucson Children’s Respiratory Study. Pediatr Pulmonol 41:318–325

    Article  PubMed  Google Scholar 

  24. Almqvist C, Worm M, Leynaert B (2008) Impact of gender on asthma in childhood and adolescence: a GA2LEN review. Allergy 63:47–57

    CAS  PubMed  Google Scholar 

  25. Rönmark E, Perzanowski M, Platts-Mills T, Lundback B (2002) Incidence rates and risk factors for asthma among school children: a 2-year follow-up report from the obstructive lung disease in Northern Sweden (OLIN) studies. Respir Med 96:1006–1013

    Article  PubMed  Google Scholar 

  26. Kozyrskyj AL, Mustard CA, Becker AB (2004) Identifying children with persistent asthma from health care administrative records. Can Respir J 11:141–145

    PubMed  Google Scholar 

  27. Martinez FD, Wright AL, Taussig LM, Holberg CJ, Halonen M, Morgan WJ, The Group (1995) Asthma and wheezing in the first six years of life. N Engl J Med 332:133–138

    Article  CAS  PubMed  Google Scholar 

  28. Stein RT, Martinez FD (2004) Asthma phenotypes in childhood: lessons from an epidemiological approach. Paediatr Respir Rev 5:155–161

    Article  PubMed  Google Scholar 

  29. Pekkanen J, Sunyer J (2008) Problems in using incidence to analyze risk factors in follow-up studies. Eur J Epidemiol 23:581–584

    Article  CAS  PubMed  Google Scholar 

  30. Saglani S, Bush A (2009) Asthma in preschool children: the next challenge. Curr Opin Allergy Clinical Immunology 9:141–145

    Article  Google Scholar 

  31. Beardon PH, McGilchrist MM, McKendrick AD, McDevitt DG, MacDonald TM (1993) Primary non-compliance with prescribed medication in primary care. Br Med J 307:846–848

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Øystein Karlstad.

Additional information

Sources of funding

This work was funded by the Research Council of Norway.

Disclosure of potential conflict of interest

All authors declare that they have no conflict of interest.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Karlstad, Ø., Nafstad, P., Tverdal, A. et al. Prevalence, incidence and persistence of anti-asthma medication use in 2- to 29-year-olds: a nationwide prescription study. Eur J Clin Pharmacol 66, 399–406 (2010). https://doi.org/10.1007/s00228-009-0749-x

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00228-009-0749-x

Keywords

Navigation